MALARIA – WHO
December 1st, 2002
BY KEITH NUTHALL
AN INTERNATIONAL agreement has been signed to develop a new combination anti-malaria drug. Called pyronaridine-artesunate, it will be jointly developed by the Tropical Diseases Research Programme, the Medicines for Malaria Venture and South Korea's Shin Poong Pharmaceuticals. It could be registered by early 2006. The World Health Organisation said one tablet would be taken daily.
AN INTERNATIONAL agreement has been signed to develop a new combination anti-malaria drug. Called pyronaridine-artesunate, it will be jointly developed by the Tropical Diseases Research Programme, the Medicines for Malaria Venture and South Korea's Shin Poong Pharmaceuticals. It could be registered by early 2006. The World Health Organisation said one tablet would be taken daily.
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.